Polyol profiles in Down syndrome. myo-Inositol, specifically, is elevated in the cerebrospinal fluid.
Open Access
- 1 February 1995
- journal article
- clinical trial
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 95 (2) , 542-546
- https://doi.org/10.1172/jci117696
Abstract
Polyols are reduction products of aldoses and ketoses; their concentrations in tissues can reflect carbohydrate metabolism. Several polyol species were quantitated in cerebrospinal fluid (CSF) and plasma from 10 Down Syndrome (trisomy 21) subjects between the ages of 22 and 63 years (3 of whom were demented) and from 10 healthy age-matched controls, using a gas chromatographic/mass spectrometric technique. The mean CSF concentration and the mean CSF/plasma concentration ratio of myo-inositol were significantly elevated in Down syndrome compared with controls, but were not correlated with the presence of dementia in the Down subjects. Plasma myo-inositol was not significantly altered in these subjects. No significant difference between Down syndrome and controls was found for CSF concentrations of mannitol, sorbitol, galactitol, ribitol, arabitol, or 1,5-anhydrosorbitol, but plasma mannitol, ribitol and arabitol were elevated in Down syndrome. The present observation provides new impetus for studying synthesis and transport of myo-inositol as well as phosphatidylinositol cycle in trisomy 21 disorder.Keywords
This publication has 26 references indexed in Scilit:
- Lumbar Cerebrospinal Fluid Choline in Healthy Aging and in Down's SyndromeArchives of Neurology, 1990
- Regional Cerebral Glucose Metabolism is Normal in Young Adults with down SyndromeJournal of Cerebral Blood Flow & Metabolism, 1990
- Neural and developmental actions of lithium: A unifying hypothesisCell, 1989
- Neuropsychological evaluation of adults with Down's syndrome: patterns of selective impairment in non‐demented old adultsJournal of Intellectual Disability Research, 1989
- Myo-inositol transport through the blood-brain barrierNeurochemical Research, 1988
- Decline in cerebral glucose utilisation and cognitive function with aging in Down's syndrome.Journal of Neurology, Neurosurgery & Psychiatry, 1987
- Metabolism and Function of myo-Inositol and Inositol PhospholipidsAnnual Review of Nutrition, 1986
- Report of the committee on the genetic constitution of chromosomes 20, 21, and 22Cytogenetic and Genome Research, 1985
- CEREBRAL GLUCOSE UTILIZATION, AS MEASURED WITH POSITRON EMISSION TOMOGRAPHY IN 21 RESTING HEALTHY MEN BETWEEN THE AGES OF 21 AND 83 YEARSBrain, 1983
- Myo‐Inositol Turnover in the Intact Rat Brain: Increased Production after d‐AmphetamineJournal of Neurochemistry, 1981